Product details
Background:Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator.
• TGFB1 induces fetal reprogramming and enhances intestinal regeneration., PMID:37865088
• Biomarkers for the identification of cardiac fibroblast and myofibroblast cells., PMID:29987445
• Association between TGF-β gene polymorphism and myopia: A systematic review and meta-analysis., PMID:35905284
• A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis., PMID:38980870
• The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis., PMID:35525938
• Lack of association between the TGF-β(1) gene and development of COPD in Asians: a case-control study and meta-analysis., PMID:21556788
• TGF-β and Diabetic Nephropathy: Lessons Learned Over the Past 20 Years., PMID:32039767
• Direct effect of transforming growth factor-beta 1 (TGF-β1) on human apical papilla cell proliferation and mineralisation., PMID:34596309
• Concentration change of TGF -β 1 in aqueous humor of rabbits., PMID:24507648
• TGF-beta 1 codon 10 polymorphism is associated with cerebral SVD., PMID:22030425






